|
RNF168 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.28440005484765E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.33029978331012E-10 |
| Normal-vs-Stage2 |
4.075300E-03 |
| Normal-vs-Stage3 |
1.876670E-03 |
| Normal-vs-Stage4 |
2.472200E-02 |
| Stage1-vs-Stage2 |
5.268000E-01 |
| Stage1-vs-Stage3 |
5.105800E-01 |
| Stage1-vs-Stage4 |
8.429600E-01 |
| Stage2-vs-Stage3 |
9.702200E-01 |
| Stage2-vs-Stage4 |
5.960000E-01 |
| Stage3-vs-Stage4 |
6.181800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.83829995670237E-09 |
| Normal-vs-AfricanAmerican |
6.54090000051788E-07 |
| Normal-vs-Asian |
3.01160000004685E-06 |
| Caucasian-vs-AfricanAmerican |
8.810000E-01 |
| Caucasian-vs-Asian |
2.909000E-01 |
| AfricanAmerican-vs-Asian |
2.308200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.36149980178857E-10 |
| Normal-vs-Female |
2.911900E-02 |
| Male-vs-Female |
7.459700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.74899999950374E-07 |
| Normal-vs-Extreme_Weight |
3.31139560216798E-11 |
| Normal-vs-Obese |
1.594060E-04 |
| Normal-vs-Extreme_Obese |
2.426300E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.095600E-01 |
| Normal_Weight-vs-Obese |
1.050570E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.446400E-01 |
| Extreme_Weight-vs-Obese |
1.289930E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.333000E-01 |
| Obese-vs-Extreme_Obese |
5.293600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.299600E-03 |
| Normal-vs-Age(41-60Yrs) |
1.79248999999659E-05 |
| Normal-vs-Age(61-80Yrs) |
1.30790045460571E-10 |
| Normal-vs-Age(81-100Yrs) |
4.15080003701718E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.728200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.670800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.112100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.690000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.420810E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.694000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.56350044022702E-10 |
| Normal-VS-Type2 PRCC |
2.00630001501167E-09 |
| Normal-VS-KIRP CIMP |
6.955200E-01 |
| Normal-VS-Unclassified PRCC |
1.359620E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.615200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.507940E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.156000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.389960E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.558000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.414600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.85407245112401E-13 |
| Normal-vs-N1 |
8.241100E-03 |
| Normal-vs-N2 |
4.263600E-01 |
| N0-vs-N1 |
4.808300E-02 |
| N0-vs-N2 |
4.857600E-01 |
| N1-vs-N2 |
9.284800E-01 |
|
|
